Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
ConclusionsHBsAg seroclearance rapidly occurs following antiviral therapy for reactivation of resolved HBV infection, suggesting distinct clinical phenotypes as well as shorter duration of HBV infection associated with this particular disease setting-HBV reactivation.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
More News: Antiviral Therapy | Cancer | Cancer & Oncology | Cancer Therapy | Gastroenterology | Hepatitis | Hepatitis B | Rituxan | Stem Cell Therapy | Stem Cells | Study | Transplants